Novel Native
Reversed-Phase Liquid Chromatography
(nRPLC)/MS for Antibody–Drug Conjugates (ADCs) Characterization
and Drug–Antibody Ratio (DAR) Assessment
Posted on 2025-03-31 - 19:36
Characterization of drug–antibody ratio (DAR)
species in
antibody–drug conjugates (ADCs) is crucial for assessing the
developability/manufacturability and downstream development of drug
candidates. Although hydrophobic interaction chromatography (HIC)
is the gold standard for DAR analysis, elucidating DAR species within
each HIC peak has historically been challenging. This is due to the
nonvolatility and high ionic strength of conventional buffer systems,
which necessitate labor-intensive offline fractionation, followed
by MS analysis. To address these challenges, an innovative alternative
strategy has been developed that directly couples native reversed-phase
liquid chromatography (nRPLC) to high-resolution Orbitrap MS for online
native MS analysis (nRPLC-MS). In collaboration with Phenomenex, two
types of columns, each with a different hydrophobicity, were developed,
allowing for elution with low concentration of MS-friendly salt and
organic buffer. LC and MS parameters were optimized to enhance the
detection of intact DAR species under high flow rate conditions. To
demonstrate the feasibility of the platform for characterizing different
types of ADCs, both interchain-linked (heterogeneous DAR of 0 to 8)
and site-specific ADCs were evaluated. The method enables the nondenatured
separation and simultaneous characterization of different DAR species,
and strong correlation was observed between this approach and analysis
by HIC. This integrated strategy allows unbiased characterization
of DAR species without postcolumn flow splitting or peak fractionation.
Furthermore, comparisons with two commonly used methods (native SEC-MS
and RPLC-MS) have shown that superior separation in terms of selectivity
and resolution is achieved with the nRPLC method. Notably, unconjugated
antibody (DAR0) was successfully retained with a low-ionic-strength
salt using this method. Moreover, the method facilitated the chromatographic
separation of positional isomers of DAR4 species with different conjugation
linkages, which was not achievable with traditional HIC. As a result,
this method holds great promise for high-throughput screening and
characterization of ADCs across conjugation methods and payload classes.
CITE THIS COLLECTION
DataCiteDataCite
No result found
Ma, Fengfei; Sanchez, A. Carl; Song, James; Kofman, Esther; Tomazela, Daniela; Fayadat-Dilman, Laurence; et al. (2025). Novel Native
Reversed-Phase Liquid Chromatography
(nRPLC)/MS for Antibody–Drug Conjugates (ADCs) Characterization
and Drug–Antibody Ratio (DAR) Assessment. ACS Publications. Collection. https://doi.org/10.1021/acs.analchem.4c05885